TWST
Twist Bioscience

1 report on Twist Bioscience (TWST) by Nathaniel Horwitz, summarized: the thesis, evidence and key numbers. Latest: Nov 5, 2026.

No spam. Unsubscribe anytime.

All Reports TWST × / Market Intelligence

TWST

1 of 1 reports

Hunterbrook says Twist Bioscience's TWST rally to $200 may have overshot amid AI-fueled enthusiasm, competition, and valuation risk.